Alnylam Pharmaceuticals · 3 weeks ago
Scientist, Organic Synthesis
United States
Full-time
Remote
Senior Level
$117K/yr - $158K/yr
7+ years expAlnylam Pharmaceuticals is a leader in RNAi therapeutics, and they are seeking a Scientist, Organic Synthesis to develop and optimize specialty starting materials for oligonucleotide drug manufacturing. The successful candidate will collaborate with cross-functional teams and external partners to ensure effective process development and compliance with regulatory standards.
BiotechnologyHealthcarePharmaceuticalHealth CareMedicalTherapeutics
No H1B
Responsibilities
Contribute to process development, optimization, and scale-up of speciality starting materials
Support the process and product characterization of small molecules and oligonucleotide APIs
Contribute to the management and optimization of in-house and contract manufacturing processes
Author and review technical protocols and development reports in support of manufacturing and process characterization activities for CTA filing
Author, edit, and review manufacturing documentation according to regulatory and procedural guidelines
Support RA activities with authoring starting materials related
Work closely with analytical development, manufacturing technical operations, QA, QC, supply chain, Regulatory Affairs and CMO/CRO on the process transfer and process optimization
Contribute to strategic technical discussions and presenting progress at internal and external scientific meetings
Qualification
Required
Ph.D. in chemistry, chemical engineering, or biochemical engineering or B.S./M.S. with 7+ years of relevant experience
Process research and development experience in organic synthesis
Demonstrated proficiency in the design and development of practical processes for manufacture of small molecules, peptides and oligonucleotides
Hands-on experience in process development and analytical methods for process and product characterization
Excellent interpersonnel, organizational and communication skills
Demonstrated strong operational execution and problem-solving skills
Desire to work in a fast-paced, deadline-driven work environment
Benefits
Annual short-term incentive award (e.g., bonus or sales incentive)
Annual long-term incentive award (e.g., equity)
Medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
401(k)with a generous company match
Paid time off, wellness days, holidays, and two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Company data provided by crunchbase